ZMIZ2 and bladder transitional cell carcinoma: ,21 Pan-cancer analysis revealed that the expression of ZMIZ2 was highly expressed in many types of cancers, such as bladder urothelial carcinoma, breast cancer, rectum adenocarcinoma, stomach adenocarcinoma, and head and neck tumor (Figure 1a).